Benefit shown in off-label use of catheter aortic-valve repair

Article discusses the benefit in off-label use of catheter aortic-valve repair. Among patients not in FDA-approved groups, catheter-based procedures are found to have similar 1-year mortality outcomes to open-heart surgery.

Download Document

The browser you're using does not support embedded PDFs. Please click the button above to download a copy of this document.